ChemoCentryx, Inc. (CCXI) Friday reported a wider loss for the second quarter, due mainly to lower margins.
Net loss for the quarter widened to $10.9 million or $0.30 per share from $7.9 million or $1.90 per share in the same quarter last year.
Analysts polled by Thomson Reuters expected the company to earn $0.21 per share for the quarter. Analysts' estimates typically exclude special items.
Revenues totaled $1.1 million, down from $1.2 million last year.
Operating expenses increased to $12.2 million from $9.2 million last year.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.